|
|
Volumn 8, Issue 10, 1999, Pages 1673-1682
|
|
Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer's disease: Review and current status
|
|
Author keywords
Acetylcholinesterase inhibitor; Alzheimer's disease; Dementia; ENA 713; SDZ ENA 713
|
|
Indexed keywords
CHOLINESTERASE INHIBITOR;
CYTOCHROME P450;
RIVASTIGMINE;
ABDOMINAL PAIN;
ALZHEIMER DISEASE;
AMNESIA;
CAREGIVER;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
COGNITION;
DAILY LIFE ACTIVITY;
DIARRHEA;
DRUG BLOOD LEVEL;
DRUG CEREBROSPINAL FLUID LEVEL;
DRUG DISTRIBUTION;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG TOLERABILITY;
FOREBRAIN;
HIPPOCAMPUS;
HUMAN;
MAJOR CLINICAL STUDY;
META ANALYSIS;
NAUSEA;
NEUROTRANSMISSION;
ORAL DRUG ADMINISTRATION;
REVIEW;
VERTIGO;
VOMITING;
|
|
EID: 0032860308
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.10.1673 Document Type: Review |
|
Times cited : (87)
|
|
References (47)
|
